AEA drug
Evidence from:
primary |
all sources
Related entities (5)
| Subject | Relation | Object | p-value | Evidence |
|---|---|---|---|---|
| AEA | associated_with | AA | — | 1 |
| AEA | interacts_with | CB1 receptor | — | 1 |
| AEA | interacts_with | CB2 | — | 1 |
| FAAH | regulates | AEA | — | 1 |
| glucocorticoid | regulates | AEA | — | 1 |
Mentioned in (10)
Papers in which this entity is mentioned.
- Prenatal drug exposure and neurodevelopmental programming of glucocorticoid signalling. (2020)
- The Role of the Endocannabinoid System and Genetic Variation in Adolescent Brain Development. (2018)
- Dose-dependent teratogenicity of the synthetic cannabinoid CP-55,940 in mice. (2016)
- Cognitive Impairment Induced by Delta9-tetrahydrocannabinol Occurs through Heteromers between Cannabinoid CB1 and Serotonin 5-HT2A Receptors. (2015)
- Programming of neural cells by (endo)cannabinoids: from physiological rules to emerging therapies. (2014)
- Neuronal substrates and functional consequences of prenatal cannabis exposure. (2014)
- Adolescent chronic mild stress alters hippocampal CB1 receptor-mediated excitatory neurotransmission and plasticity. (2013)
- Cannabinoid receptor 1 signaling in embryo neurodevelopment. (2012)
- Soluble epoxide hydrolase inhibition, epoxygenated fatty acids and nociception. (2011)
- Acute ethanol suppresses glutamatergic neurotransmission through endocannabinoids in hippocampal neurons. (2008)
Merged raw entities (2)
All extracted name/type variants the normalize job merged into this entity. Use this to spot wrong merges, or aliases that should be split off.
| Raw name | Type | Papers | Mentions |
|---|---|---|---|
| aea | drug | 10 | 48 |
| arachidonylethanolamine | drug | — | — |